HCA Healthcare Inc [HCA] stock prices are up 4.66% to $467.86 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The HCA shares have gain 8.01% over the last week, with a monthly amount glided 11.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wolfe Research downgraded its rating to Peer Perform on July 28, 2025. On July 16, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $394 on the stock. Wells Fargo upgraded its rating to a Equal Weight but stick to its price target of $385 on May 29, 2025. Robert W. Baird downgraded its rating to a Neutral but $336 remained the price target by the analyst firm on April 15, 2025. In a note dated November 25, 2024, Wells Fargo downgraded an Underweight rating on this stock and revised its target price from $400 to $320.
The stock price of HCA Healthcare Inc [HCA] has been fluctuating between $289.98 and $461.56 over the past year. Currently, Wall Street analysts expect the stock to reach $483.33 within the next 12 months. HCA Healthcare Inc [NYSE: HCA] shares were valued at $467.86 at the most recent close of the market. An investor can expect a potential return of 3.31% based on the average HCA price forecast.
Analyzing the HCA fundamentals
The HCA Healthcare Inc [NYSE:HCA] reported sales of 74.37B for trailing twelve months, representing a surge of 9.57%. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is -1.61 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 454.71 points at the first support level, and at 441.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 475.09, and for the 2nd resistance point, it is at 482.33.
Ratios To Look Out For
It’s worth pointing out that HCA Healthcare Inc [NYSE:HCA]’s Current Ratio is 0.85. On the other hand, the Quick Ratio is 0.76, and the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 1.47 and price to earnings (TTM) ratio is 18.08.
Transactions by insiders
Recent insider trading involved Cuffe Michael S., Officer, that happened on Sep 08 ’25 when 3836.0 shares were purchased. EVP and Chief Clinical Officer, Cuffe Michael S. completed a deal on Sep 08 ’25 to sell 3836.0 shares. Meanwhile, EVP and COO Foster Jon M sold 15698.0 shares on May 13 ’25.
